Core Insights - The Pennant Group, Inc. (PNTG) reported a revenue of $219.5 million for the quarter ended June 2025, reflecting a year-over-year increase of 30.1% and surpassing the Zacks Consensus Estimate by 3.16% [1] - Earnings per share (EPS) for the quarter was $0.27, up from $0.24 in the same quarter last year, exceeding the consensus EPS estimate of $0.26 by 3.85% [1] Revenue Breakdown - Total revenue from home health and hospice services was $166.02 million, exceeding the average estimate of $162.09 million by analysts, with a year-over-year growth of 32.5% [4] - Revenue from senior living services reached $53.48 million, surpassing the two-analyst average estimate of $50.75 million, marking a year-over-year increase of 23.1% [4] - Home care and other services within home health and hospice generated $13.06 million, which was below the average estimate of $15.32 million, but still showed a significant year-over-year growth of 202.4% [4] - Hospice services revenue was $73.77 million, exceeding the average estimate of $71.57 million, with a year-over-year increase of 24.3% [4] - Home health services revenue amounted to $79.19 million, surpassing the average estimate of $75.16 million, reflecting a year-over-year growth of 28.5% [4] Stock Performance - The Pennant Group's shares have returned -14.1% over the past month, contrasting with the Zacks S&P 500 composite's increase of 0.5% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]